Novartis Oncology Financial Analyst Salary
The average Novartis Oncology Financial Analyst earns an estimated $95,114 annually, which includes an estimated base salary of $82,534 with a $12,580 bonus. Novartis Oncology's Financial Analyst compensation is $7,714 more than the US average for a Financial Analyst. Financial Analyst salaries at Novartis Oncology can range from $54,000 - $150,000.
The Finance Department at Novartis Oncology earns $23,951 more on average than the Admin Department.
Last updated 3 years ago.
- $82,534
- avg. base
- $12,580
- avg. bonus
Financial Analyst Salaries at Novartis Oncology
Financial Analysts earn $2,824 more than Business Analysts, and $9,592 less than Accounting Managers.
Compensation at Novartis Oncology by Department
The Finance Department averages $23,951 more than the Admin Department, and $6,796 less than the Operations Department
Financial Analyst Compensation by Gender (All Companies)
The average female Financial Analyst at companies similar size to Novartis Oncology reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.
Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Financial Analyst at companies similar size to Novartis Oncology reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.
How Financial Analysts at Novartis Oncology Rate Their Compensation
The majority of Financial Analysts at Novartis Oncology believe they're not compensated fairly. 100% of Financial Analysts at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
